Article info

Original research
Targeting disialoganglioside GD2 with chimeric antigen receptor-redirected T cells in lung cancer

Authors

  • Loïc Reppel Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA PubMed articlesGoogle scholar articles
  • Ourania Tsahouridis Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA PubMed articlesGoogle scholar articles
  • Jason Akulian Division of Pulmonary and Critical Care, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA PubMed articlesGoogle scholar articles
  • Ian J Davis Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USADepartment of Pediatrics, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA PubMed articlesGoogle scholar articles
  • Hong Lee Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA PubMed articlesGoogle scholar articles
  • Giovanni Fucà Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA PubMed articlesGoogle scholar articles
  • Jared Weiss Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USADivision of Oncology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA PubMed articlesGoogle scholar articles
  • Gianpietro Dotti Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USADepartment of Microbiology and Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA PubMed articlesGoogle scholar articles
  • Chad V Pecot Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USADivision of Oncology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA PubMed articlesGoogle scholar articles
  • Barbara Savoldo Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USADepartment of Pediatrics, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Barbara Savoldo; bsavoldo{at}med.unc.edu
View Full Text

Citation

Reppel L, Tsahouridis O, Akulian J, et al
Targeting disialoganglioside GD2 with chimeric antigen receptor-redirected T cells in lung cancer

Publication history

  • Accepted November 14, 2021
  • First published January 12, 2022.
Online issue publication 
January 12, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.